All News about Lexaria Bioscience Corp
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program
January 16, 2024
Via ACCESSWIRE
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
January 10, 2024
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting New and More Lucrative Global Markets
December 15, 2023
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria's Investigational New Drug Application Filing Update
December 07, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|